Investor Class Action Filed Against Depomed, Inc. for Securities Fraud Violations
Company Name: Depomed, Inc.
Court: United States District Court for the Northern District of California
Case Number: 17-cv-04830
Judge: The Hon. Jon S. Tigar
Class period: Between February 26, 2015 and August 7, 2017
Security Type: Common Stock

Case Background:

On August 18, 2017, the initial complaint in this securities class action was filed against Depomed, Inc. (“Depomed” or the “Company”), and certain of Depomed’s directors, officers and underwriters, asserting violations of sections 10(b) and 20(a) of the Securities Exchange Act.

The complaint alleges that throughout the class period, defendants issued materially false and/or misleading statements and/or failed to disclose that: (i) Depomed engaged in questionable practices in connection with the sales and marketing of the Company’s opioid products; (ii) the foregoing conduct, when it became known, would likely subject the Company to heightened legal and regulatory scrutiny; and (iii) as a result, Depomed’s public statements were materially false and misleading at all relevant times.

Current Status of Case:

On March 11, 2020, the Court granted defendants’ Motion to Dismiss.  On April 9, 2020, Plaintiffs filed an appeal with the United States Court of Appeals for the Ninth Circuit.  This action is still ongoing. 

If you would like additional information about the suit, please click on the link "Submit Your Information" above and fill out the form as promptly as possible.

Kessler Topaz Meltzer & Check, LLP
James Maro, Esq. or Adrienne Bell, Esq.
280 King of Prussia Road
Radnor, PA 19087 1-844-887-9500 (toll free) or 1-610-667-7706
Or by e-mail at

Please complete this form relating to your transactions for Depomed, Inc.(Nasdaq: DEPO) securities between February 26, 2015 and August 7, 2017, inclusive (the "Class Period"). 

You may also contact James Maro, Jr., Esq. or Adrienne Bell, Esq. at 610.667.7706 or toll free at 844.887.9500, or you may submit your information via email at, or you may click here to print a PDF of this form.

* Denotes required field
# of Shares
Price per Share
Principal Amount
Amount Paid
Series or CUSIP
# of Contracts
Price per Contract
Exercise Price
Expiration Date
Did you purchase shares of Depomed, Inc. (2017) prior to the Class Period?
Are you a current or former employee of Depomed, Inc. (2017)?
The submission of this form does not create an attorney-client relationship, nor an obligation on the part of Kessler Topaz or you to file a lead plaintiff motion in this matter. Any information you submit will be maintained as confidential. If Kessler Topaz, in its sole discretion, believes that you might be an appropriate lead plaintiff candidate, Kessler Topaz will contact you to discuss the matter and whether to establish an attorney client relationship. By signing this form you are authorizing us to contact you regarding this case and/or future cases.
I agree to the KTMC
I would like to receive
new case alerts by email